Personal Genomics

What Personal Genomics does

Personal Genomics (Personal Genomics unipersonale Srl) is a Verona-based medical genetics laboratory providing Next Generation Sequencing (NGS) genomic analysis and data interpretation services to clinical and research customers in Italy. The company operates two service lines: Clinical Diagnostics, offering CE-IVD marked genetic tests spanning reproductive health (Personal Vision NIPT in Basic, Medium, Full, and Platinum tiers), cardiovascular risk, oncology, infectious disease (COVID-19, HPV, STD panels), pediatric neuropsychiatry (Fragile X, Autism WGS), and microbiome analysis; and NGS Custom Services, providing DNA sequencing, RNA sequencing, and metagenomics to research institutions and universities. Underlying capabilities include an internal bioinformatics pipeline optimized for real (not theoretical) coverage, custom library preparation protocols, and a proprietary Italian population variant database supporting more effective rare variant identification. The laboratory holds Veneto Region accreditation, the highest recognition of suitability to provide health services for the Italian National Health System (SSN), and participates in international External Quality Verification (VEQ) circuits.

The business model is professional services revenue, with clinical test fees reimbursed through regional SSN agreements (notably Veneto) and direct patient payment via the Doctolib booking platform and home nursing sample collection. Marketing is conducted primarily through participation in medical congresses (SIGU, ESHRE, SIRU) and professional networks rather than digital channels, and the customer base is concentrated in Italian healthcare providers, SSN-referred patients, and research institutions. The company was founded in 2011 as a University of Verona spin-off, became a University of Bologna spin-off in 2013, and was acquired by SOL Group in 2017, where it operates within the Biotechnology Division alongside Diatheva and CryoLab. Headcount is 1-10, with leadership under CEO Stefania Mariani, and operations remain entirely domestic.

Name

Personal Genomics

Legal name

Personal Genomics unipersonale Srl

Website

https://personalgenomics.it

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Personal Genomics is a Verona-based, SOL Group-owned medical genetics laboratory providing CE-IVD marked Next Generation Sequencing clinical diagnostics and custom NGS research services to Italian healthcare providers, SSN patients, and research institutions.

Ownership category

akta.pro rank

Product category

Clinical Genetic Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Genomic sequencing services
• Clinical genetic testing
• Non-invasive prenatal testing
• Medical genetics laboratory
• NGS bioinformatics analysis

Headquarters

HQ city

Verona

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Diagnostic Testing: Genetic testing services for patients including prenatal screening, cardiovascular risk assessment, cancer genetic testing, infectious disease detection, and pediatric neuropsychiatry testing. Services delivered through accredited laboratory for Italian National Health System (SSN).
2. NGS Custom Services: Custom next-generation sequencing services for research projects including DNA sequencing, RNA sequencing, and metagenomics. Supports complex research projects through design, library preparation, sequencing, and bioinformatics analysis.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Personal Genomics is a medical genetics laboratory providing Next Generation Sequencing (NGS)-based clinical diagnostic tests and custom research sequencing services. The clinical diagnostics line covers prenatal screening (NIPT), oncology profiling, cardiovascular risk, infectious disease detection, and pediatric neuropsychiatry testing. The NGS custom services line delivers DNA sequencing, RNA sequencing, and metagenomics for universities and research institutions. The laboratory is authorized and accredited to perform tests for the Italian National Health System (SSN).

Product overview

Personal Genomics is a medical genetics laboratory providing Next Generation Sequencing (NGS) genomic analysis and data interpretation services for clinical diagnostics and research. The company operates a platform-based model with two main service lines: Clinical Diagnostics (offering genetic tests for oncology, prenatal screening including Personal Vision NIPT, cardiovascular risk panels, pharmacogenomics, and pathogen detection) and NGS Custom Services (offering DNA/RNA sequencing and metagenomics for research clients). The product portfolio spans reproductive health tests (Personal Vision NIPT, carrier screening), cardiovascular assessments (cardiomyopathy, cardiovascular risk, congenital heart disease panels), infectious disease testing (COVID-19, HPV, STD panels), and custom NGS services for research institutions. The company is authorized by the Italian National Health System (SSN) and accredited by the Veneto Region. In 2017, Personal Genomics became part of the SOL Group, a biotechnology division alongside Diatheva (diagnostic systems) and CryoLab (biobanking).

Differentiator

Problem solved

Functional benefit

Products and services

• Personal Vision (NIPT) Non-Invasive Prenatal Test (NIPT) that analyzes circulating fetal DNA from maternal blood to screen for chromosomal aneuploidies and microdeletions. CE-IVD certified.
• Fragile X Syndrome Genetic Test Genetic test that determines the number of CGG triplets in the FMR1 gene for diagnosis of Fragile X Syndrome, an X-linked hereditary condition causing intellectual disability. CE-IVD certified.
• Autism Spectrum Disorder Genetic Test Whole genome sequencing test using NGS technology to identify sequence variants and large rearrangements associated with Autism Spectrum Disorders, evaluating variants against the SFARI Gene database. CE-IVD certified.
• Cardiovascular Risk Genetic Test NGS-based test analyzing coding sequences of genes associated with cardiovascular conditions including familial hypercholesterolemia (APOB, LDLR, PCSK9) and atherosclerotic lesions (ANKRD1).
• Cardiomyopathy Risk Panel Multi-gene NGS panel testing for dilated, mitochondrial, arrhythmogenic, and hypertrophic cardiomyopathies, analyzing 50+ genes including MYH7, MYBPC3, LMNA, and others.
• Congenital Heart Disease Risk Panel NGS panel for detecting genetic variants associated with congenital heart diseases including familial amyloidosis (TTR), Anderson-Fabry disease (GLA), and inter-atrial defects.
• COVID-19 Molecular Test Real-time RT-PCR test detecting SARS-CoV-2 viral RNA from respiratory secretions. Includes COVID-ID variant identification and COVID-FLU differential testing options. Diagnostic sensitivity and specificity >99%.
• HPV Testing Molecular tests for Human Papillomavirus detection using CE-IVD Anyplex II HPV28 Detection kit. Options include HPV 14 high-risk strains and HPV 28 strains (19 high risk + 9 low risk) panels.
• Panel of 7 Sexually Transmitted Diseases Multiplex PCR test using CE-IVD Anyplex TM II STI-7 Detection kit to identify Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium/hominis, Ureaplasma urealyticum/parvum, and Trichomonas vaginalis.
• Personal Microbioma Intestinal microbiome genetic test using NGS sequencing of hypervariable gene regions from stool samples to classify bacterial populations, assess biodiversity index, and identify dysbiosis.
• Genetic Testing of Solid Tumors Oncology genetic tests for diagnosis, prognosis assessment, and personalized therapy selection based on tumor genetic profiling.
• Predictive Genetic Testing of Female Cancer Genetic screening for breast, ovarian, and endometrial cancer prevention with high quality standards throughout the production process.
• Prenatal and Preconceptional Genetic Tests Non-invasive genetic tests for prenatal and preconception screening including Combined Test, NIPT (Personal Vision), fetal Rh genotyping, and carrier screening for conditions like SMA, thalassemia, and cystic fibrosis.
• Medically Assisted Reproduction Genetic Services Genetic tests to determine optimal assisted reproduction methods based on couple's medical history to optimize probability of positive outcomes.
• DNA Sequencing Services Custom NGS services for genome, exome, and custom gene panel analysis including sample treatment, library preparation, sequencing, and bioinformatics analysis for research clients.
• RNA Sequencing Services NGS services for WTS, RNA-Seq, and miRNA-Seq analysis with complete service from sample treatment to bioinformatics analysis.
• Metagenomics Services Genomic techniques for microbial community study using 16S/ITS amplicon sequencing, shotgun sequencing, and whole genome sequencing of bacterial/viral genomes.

Quantifiable outcome

• Customer Satisfaction Rating for Research Services: 9.13/10 (2024), exceeding ≥8 target
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Scale indicators5 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• Eurofins Genomics: A leading European provider of genomic services including DNA sequencing, genotyping, and bioinformatics for clinical and research customers. Comparable to Personal Genomics as a full-service NGS laboratory serving both research and clinical diagnostics, but with much broader geographic reach and a wider service portfolio.
• BGI Genomics: One of the world's largest genomics organizations offering NGS services, NIPT, and clinical genetic testing globally. Comparable to Personal Genomics in offering CE-IVD NIPT and clinical genomics, though at vastly greater scale and with international infrastructure.
• Natera: Public US-based genetic testing company specializing in reproductive health (NIPT, carrier screening, preimplantation) and oncology. Comparable to Personal Genomics in reproductive and oncology genetic testing, with overlapping NIPT and hereditary cancer product lines.
• Bioscientia (Sonic Healthcare): European medical laboratory network offering genetic diagnostics, NGS testing, and clinical pathology services as part of Sonic Healthcare. Comparable to Personal Genomics as a clinical laboratory with genetic and genomic testing menu serving physicians and hospitals, with much broader geographic and service coverage.

Direct peers

• Centogene: Specialized clinical diagnostics company focused on rare disease genetics and NGS-based testing for hospitals and physicians. Closely comparable to Personal Genomics in providing genetic and genomic diagnostic testing, with overlapping product lines in NIPT, hereditary cancer, and rare disease panels.
• Dante Labs: European (Italy-headquartered) consumer and clinical genomics company offering whole genome sequencing, NIPT, and rare disease testing. Comparable as a direct competitor in the Italian market for NGS-based clinical diagnostics, particularly in NIPT and personalized medicine.
• Igenomix (Vitrolife Group): Specialized reproductive genetics laboratory offering NIPT, PGT, carrier screening, and reproductive genetic diagnostics globally. Comparable to Personal Genomics' reproductive/prenatal service line including Personal Vision NIPT and medically assisted reproduction testing.
• Novogene: Global NGS service provider offering DNA sequencing, RNA sequencing, and bioinformatics analysis for research and clinical applications. Comparable to Personal Genomics' NGS Custom Services line for research institutions, with similar library preparation and bioinformatics capabilities.
• Macrogen: Genomics service provider offering DNA sequencing, genome analysis, and clinical diagnostics across Asia, Europe, and the Americas. Comparable to Personal Genomics across both custom NGS research services and clinical diagnostics with CE-IVD workflows.

Regional players

• Medicover Genetics: European clinical genetics laboratory offering NIPT, carrier screening, oncology genetics, and reproductive testing primarily across Central and Eastern Europe. Comparable to Personal Genomics in clinical genetics menu, though operating in different European geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/PersonalGen

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Personal Genomics